Synthesis and composition of photodynamic therapeutic agents for the targeted treatment of cancer
AssigneeOn Target Laboratories, LLC
InventorsSumith A. Kularatne, Pravin Gagare
Life of this patent
Estimating the term…
Abstract
The present invention describes new compounds that are useful for image-guided surgery and photodynamic therapy. In particular the compounds may be targeted to the nucleus or the mitochondria after compounds were delivered to diseased tissues such as cancer using a ligand that target receptor that express on the diseased tissue and followed by receptor mediated endocytosis and provide effective activity against cancer cells as well as other disorders. Methods and compositions for use of the same are described.
Claims45
A method of performing an interventional procedure, said method comprising the steps of:
- contracting biological tissue of a human or animal subject with a compound having the formula:
- or a pharmaceutically acceptable salt thereof, or isotopes thereof, wherein
- L is an amino acid,
- L/ is a linker to improve pharmacokinetic properties,
- L// is a linker which may be configured to release an organelle-targeted photodynamic therapeutic (PDT) agent,
- X is an organelle-targeting agent, and
- Y is a photodynamic therapeutic agent selected from the group consisting of:
- allowing time for the compound to distribute within the biological tissue;
- guiding a flexible probe to the biological tissue;
- and
- illuminating the tissue with an excitation light of a wavelength absorbable by the compound
- wherein the composition produces reactive oxygen species (ROSs) thereby inducing cell death and necrosis of diseased cells and destroying the biological tissue.
A method of performing an interventional procedure, said method comprising the steps of:
- administering, to human or animal subject, a compound having the formula:
- or a pharmaceutically acceptable salt thereof, or isotopes thereof, wherein
- L is an amino acid,
- L/ is a linker to improve pharmacokinetic properties,
- L// is a linker which may be configured to release an organelle-targeted photodynamic therapeutic (PDT) agent,
- X is an organelle-targeting agent, and
- Y is a photodynamic therapeutic agent selected from the group consisting of:
- allowing time for the compound to distribute within the biological tissue;
- guiding a flexible probe to the biological tissue;
- and
- illuminating the tissue with an excitation light of a wavelength absorbable by the compound wherein the composition produces reactive oxygen species (ROSs) thereby inducing cell death and necrosis of diseased cells and destroying the biological tissue.
Dependencies are inferred from the claim text.